Delayed versus early opportunistic pneumococcal conjugate vaccination in severe acute malnutrition in Timor-Leste: a randomised controlled trial (RCT)

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA332283

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2024
    2029
  • Known Financial Commitments (USD)

    $1,600,976.77
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Principal Investigator

    N/A

  • Research Location

    Australia
  • Lead Research Institution

    Menzies School of Health Research
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Vaccine design and administration

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Children (1 year to 12 years)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Not applicable

Abstract

Malnutrition is a global public health problem worsening due to effects of the COVID-19 pandemic. Recovery from malnutrition is often complicated by pneumonia or death. It is critical that malnourished children receive vaccines like the pneumococcal conjugate vaccine (PCV), which prevents pneumonia. But we don’t know when the best time is to vaccinate. This study will answer important questions about when to use PCV in children with severe acute malnutrition.